One of the world's largest pharmaceutical companies, Merck KGaA (ETR: MRK), has reiterated its commitment to its partnership with the Ugandan government via its non-profit subsidiary Merck Foundation, Pharmafile reported on Tuesday.
The partnership aims to bolster the country's healthcare abilities and treatment access in the region, with a particular emphasis in areas concerning cancer, cardiovascular disease, diabetes and infertility.
The 'Merck more than a mother' project was first launched in 2012.
"Raising awareness about male infertility is very important to change the culture as [it] affects women and men equally and yet women are the one who been solely blamed, discriminated and mistreated in their communities," commented Merck Foundation CEO Dr Rasha Kelej.
"The campaign will address this topic and encourage men to discuss openly their infertility and share the journey of infertility diagnosis and treatment with their wives."
LivaNova announces commercial launch of Essenz Perfusion System in China
Viatris' generic iron sucrose injection gains US FDA approval
CorMedix to acquire Melinta Therapeutics in USD300m deal to expand infectious disease portfolio
US FDA approves Innovent's IND application for IBI3032 oral GLP-1R agonist
GEN and Sulfateq report positive Phase 1 data for SUL-238 in Alzheimer's
Philips launches ECG AI Marketplace to streamline cardiac diagnostics
AstraZeneca's Baxdrostat meets all endpoints in pivotal Phase III hypertension trial
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Cumberland Pharmaceuticals reports ifetroban Phase 2 DMD heart disease trial results
EDX Medical and Spire Healthcare sign strategic diagnostic partnership agreement